Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6834
Title: | Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials | Authors: | Bindal, Poorva Najjar, Mimi Koehn, Kelly Godara, Amandeep Sborov, Douglas W McClune, Brian Julian, Kelley Wagner, Charlotte Mohyuddin, Ghulam Rehman |
Affiliations: | Faculty of Medicine | Issue Date: | 2023-05-11 | Publisher: | National Library of Medicine | Part of: | Leukemia and Lymphoma | Volume: | 64 | Issue: | 7 | Start page: | 1340 | End page: | 1343 | URI: | https://scholarhub.balamand.edu.lb/handle/uob/6834 | ISSN: | 10428194 | DOI: | 10.1080/10428194.2023.2209682 | Ezproxy URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
Record view(s)
35
checked on May 30, 2024
Google ScholarTM
Check
Dimensions Altmetric
Dimensions Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.